谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Paclitaxel Liposome Versus Paclitaxel in Combination with Carboplatin in the First-Line Chemotherapy for Ovarian Cancer: A Multicenter, Open-Label, Non-Inferiority, Randomized Controlled Trial

Journal of the National Cancer Center(2024)

引用 0|浏览29
暂无评分
关键词
Ovarian cancer,Paclitaxel liposome,First-line chemotherapy,Efficacy,Safety
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要